Sold 10,000 @ $135.00 avg · $1,350,000 · 2026-08-13
Form 4: Guindo Chirfi sold MRK
Guindo Chirfi (EVP, Access, Policy & Comms at Merck & Co., Inc.) reported an open-market sale of 10,000 shares of MRK at an average $135.00, roughly $1,350,000, in a Form 4 filed 2026-08-13.
At post $134.76·Now $146.87+9.0% since postedas of Sep 18, 4:30 PM ET
1d+0.8%
3d+0.8%
1w+10.6%
1m+6.8%
3m—
6m—
1y—
Sold 80,315 @ $133.46 avg · $10,718,495 · 2026-08-12
Form 4: Zachary Jennifer sold MRK
Zachary Jennifer (EVP, General Counsel at Merck & Co., Inc.) reported an open-market sale of 80,315 shares of MRK at an average $133.46, roughly $10,718,495, in a Form 4 filed 2026-08-13.
At post $134.76·Now $146.87+9.0% since postedas of Sep 18, 4:30 PM ET
1d+0.8%
3d+0.8%
1w+10.6%
1m+6.8%
3m—
6m—
1y—
Sold 45,320 @ $131.12 avg · $5,942,369 · 2026-08-10
Form 4: DeLuca Richard R. sold MRK
DeLuca Richard R. (EVP&Pres, Merck Animal Heallth at Merck & Co., Inc.) reported an open-market sale of 45,320 shares of MRK at an average $131.12, roughly $5,942,369, in a Form 4 filed 2026-08-12.
At post $132.92·Now $146.87+10.5% since postedas of Sep 18, 4:30 PM ET
1d+1.4%
3d+2.2%
1w+14.5%
1m+8.3%
3m—
6m—
1y—
Sold 6,050 @ $130.38 avg · $788,773 · 2026-08-06
Form 4: DeLuca Richard R. sold MRK
DeLuca Richard R. (EVP&Pres, Merck Animal Heallth at Merck & Co., Inc.) reported an open-market sale of 6,050 shares of MRK at an average $130.38, roughly $788,773, in a Form 4 filed 2026-08-10.
At post $130.92·Now $146.87+12.2% since postedas of Sep 18, 4:30 PM ET
1d-0.4%
3d+2.9%
1w+3.9%
1m+12.7%
3m—
6m—
1y—